300239 東寶生物
按盤價 
5.390 +0.250 (+4.864%)
5.390 +0.250 (+4.864%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.803 | 5.061 | 7.524 | 7.416 | 3.024 |
| 總資產報酬率 ROA (%) | 1.875 | 3.204 | 4.748 | 4.952 | 2.067 |
| 投入資產回報率 ROIC (%) | 2.059 | 3.748 | 5.937 | 6.498 | 2.708 | 邊際利潤分析 |
| 銷售毛利率 (%) | 24.525 | 22.722 | 25.532 | 24.744 | 15.710 |
| 營業利潤率 (%) | 10.394 | 11.999 | 14.764 | 13.835 | 6.811 |
| 息稅前利潤/營業總收入 (%) | 10.704 | 11.328 | 14.699 | 14.187 | 7.116 |
| 淨利潤/營業總收入 (%) | 9.093 | 10.313 | 13.070 | 12.236 | 5.852 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 94.593 | 95.266 | 97.068 | 94.050 | 76.278 |
| 價值變動淨收益/利潤總額(%) | -3.871 | -3.544 | -2.996 | -1.451 | -6.084 |
| 營業外收支淨額/利潤總額(%) | 0.924 | -0.519 | 0.425 | 0.860 | -0.368 | 償債能力分析 |
| 流動比率 (X) | 4.903 | 3.813 | 4.485 | 3.238 | 2.118 |
| 速動比率 (X) | 3.123 | 2.718 | 3.549 | 2.233 | 1.297 |
| 資產負債率 (%) | 32.496 | 33.734 | 30.956 | 23.927 | 24.078 |
| 帶息債務/全部投入資本 (%) | 22.857 | 22.252 | 22.027 | 10.556 | 3.565 |
| 股東權益/帶息債務 (%) | 319.260 | 332.232 | 336.709 | 803.161 | 2,548.934 |
| 股東權益/負債合計 (%) | 207.744 | 196.448 | 195.338 | 276.775 | 279.738 |
| 利息保障倍數 (X) | 50.126 | -18.593 | -114.321 | 60.964 | 21.540 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 96.106 | 74.900 | 56.917 | 56.585 | 72.317 |
| 存貨周轉天數 (天) | 260.137 | 167.401 | 148.666 | 168.312 | 220.673 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 24/03/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
